Tempus AI (TEM) lies at the core of the healthcare revolution. It uses AI to turn medical data into practical insights to ...
Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD.
Q4 Earnings: Tempus AI reported fourth-quarter revenue of $200.68 million, missing estimates of $203.12 million. The AI-focused precision medicine and patient care company reported a fourth-quarter ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
EST Tempus AI (TEM) down 7% at $64.83 after Q4 earnings miss and guidanceDiscover the Best Stocks and Maximize Your Portfolio: See what ...
Tempus AI saw its loss narrow in the fourth quarter despite booking higher costs and seeing a surge in revenue in the period. Shares fell 8.3% to $64 in post-market trading. Through Monday's close, ...
Tempus AI (NASDAQ: TEM) rocketed from about 44% higher. All on news it just acquired Ambry Genetics, a well-known leader in ...
The health care technology company posted revenue of $200.7 million in the period. For the year, the company reported a loss of $705.8 million, or $6.23 per share. Revenue was reported as $693.4 ...
Pelosi's Tempus AI call options contracts tripled in value in 40 days as the healthcare firm continued its upward rally on AI ...
TEM basically mixes genomic and clinical data with AI. This is at the core of their new offerings for precision diagnostics ...
We recently published a list of 10 Stocks Kick Off Trading Week With Losses. In this article, we are going to take a look at ...
We recently published a list of 10 AI News and Ratings You Should Not Miss. In this article, we are going to take a look at ...